Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Aurora kinases: new molecular targets in thyroid cancer therapy.

Baldini E, Sorrenti S, D'Armiento E, Prinzi N, Guaitoli E, Favoriti P, Gnessi L, Moretti C, Bianchini M, Alessandrini S, Catania A, De Antoni E, Ulisse S.

Clin Ter. 2012 Nov;163(6):e457-62. Review.

PMID:
23306762
[PubMed - indexed for MEDLINE]
2.

Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation.

Sorrentino R, Libertini S, Pallante PL, Troncone G, Palombini L, Bavetsias V, Spalletti-Cernia D, Laccetti P, Linardopoulos S, Chieffi P, Fusco A, Portella G.

J Clin Endocrinol Metab. 2005 Feb;90(2):928-35. Epub 2004 Nov 23.

PMID:
15562011
[PubMed - indexed for MEDLINE]
3.

Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT.

Baldini E, Arlot-Bonnemains Y, Sorrenti S, Mian C, Pelizzo MR, De Antoni E, Palermo S, Morrone S, Barollo S, Nesca A, Moretti CG, D'Armiento M, Ulisse S.

BMC Cancer. 2011 Sep 26;11:411. doi: 10.1186/1471-2407-11-411.

PMID:
21943074
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues.

Ulisse S, Delcros JG, Baldini E, Toller M, Curcio F, Giacomelli L, Prigent C, Ambesi-Impiombato FS, D'Armiento M, Arlot-Bonnemains Y.

Int J Cancer. 2006 Jul 15;119(2):275-82.

PMID:
16477625
[PubMed - indexed for MEDLINE]
5.

The Aurora kinases: role in cell transformation and tumorigenesis.

Katayama H, Brinkley WR, Sen S.

Cancer Metastasis Rev. 2003 Dec;22(4):451-64. Review.

PMID:
12884918
[PubMed - indexed for MEDLINE]
6.

Aurora kinases as anticancer drug targets.

Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN Jr, Gandara DR.

Clin Cancer Res. 2008 Mar 15;14(6):1639-48. doi: 10.1158/1078-0432.CCR-07-2179. Review.

PMID:
18347165
[PubMed - indexed for MEDLINE]
Free Article
7.

Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.

Li JJ, Li SA.

Pharmacol Ther. 2006 Sep;111(3):974-84. Epub 2006 Apr 17. Review.

PMID:
16603252
[PubMed - indexed for MEDLINE]
8.

Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer.

Isham CR, Bossou AR, Negron V, Fisher KE, Kumar R, Marlow L, Lingle WL, Smallridge RC, Sherman EJ, Suman VJ, Copland JA, Bible KC.

Sci Transl Med. 2013 Jan 2;5(166):166ra3. doi: 10.1126/scitranslmed.3004358.

PMID:
23283368
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues.

Ulisse S, Baldini E, Toller M, Delcros JG, Guého A, Curcio F, De Antoni E, Giacomelli L, Ambesi-Impiombato FS, Bocchini S, D'Armiento M, Arlot-Bonnemains Y.

Endocr Relat Cancer. 2007 Sep;14(3):827-37.

PMID:
17914111
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Aurora B: a new prognostic marker and therapeutic target in cancer.

Portella G, Passaro C, Chieffi P.

Curr Med Chem. 2011;18(4):482-96. Review.

PMID:
21143115
[PubMed - indexed for MEDLINE]
11.

Inhibition of the aurora kinases suppresses in vitro NT2-D1 cell growth and tumorigenicity.

Ulisse S, Arlot-Bonnemains Y, Baldini E, Morrone S, Carocci S, Di Luigi L, D'Armiento M.

J Endocrinol. 2010 Feb;204(2):135-42. doi: 10.1677/JOE-09-0257. Epub 2009 Nov 4.

PMID:
19889886
[PubMed - indexed for MEDLINE]
Free Article
12.

The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity.

Baldini E, Tuccilli C, Prinzi N, Sorrenti S, Antonelli A, Gnessi L, Catania A, Moretti C, Mocini R, Carbotta G, Morrone S, Persechino S, Redler A, De Antoni E, D' Armiento M, Ulisse S.

J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):705-15.

PMID:
24152827
[PubMed - indexed for MEDLINE]
13.

Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines.

Arlot-Bonnemains Y, Baldini E, Martin B, Delcros JG, Toller M, Curcio F, Ambesi-Impiombato FS, D'Armiento M, Ulisse S.

Endocr Relat Cancer. 2008 Jun;15(2):559-68. doi: 10.1677/ERC-08-0021. Epub 2008 Apr 22.

PMID:
18430894
[PubMed - indexed for MEDLINE]
Free Article
14.

Gene amplification and overexpression of Aurora-C in breast and prostate cancer cell lines.

Zekri A, Lesan V, Ghaffari SH, Tabrizi MH, Modarressi MH.

Oncol Res. 2012;20(5-6):241-50.

PMID:
23581231
[PubMed - indexed for MEDLINE]
15.

Aurora kinase inhibitors as anticancer molecules.

Katayama H, Sen S.

Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):829-39. doi: 10.1016/j.bbagrm.2010.09.004. Epub 2010 Sep 20. Review.

PMID:
20863917
[PubMed - indexed for MEDLINE]
Free Article
16.

Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.

Hegyi K, Méhes G.

Pathol Oncol Res. 2012 Oct;18(4):761-9. Epub 2012 Jul 29. Review.

PMID:
22843098
[PubMed - indexed for MEDLINE]
17.

Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer.

Wunderlich A, Fischer M, Schlosshauer T, Ramaswamy A, Greene BH, Brendel C, Doll D, Bartsch D, Hoffmann S.

Cancer Sci. 2011 Apr;102(4):762-8. doi: 10.1111/j.1349-7006.2011.01853.x. Epub 2011 Feb 17.

PMID:
21214672
[PubMed - indexed for MEDLINE]
18.

Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma.

Tavanti E, Sero V, Vella S, Fanelli M, Michelacci F, Landuzzi L, Magagnoli G, Versteeg R, Picci P, Hattinger CM, Serra M.

Br J Cancer. 2013 Nov 12;109(10):2607-18. doi: 10.1038/bjc.2013.643. Epub 2013 Oct 15.

PMID:
24129234
[PubMed - indexed for MEDLINE]
19.

The potential role of Aurora kinase inhibitors in haematological malignancies.

Farag SS.

Br J Haematol. 2011 Dec;155(5):561-79. doi: 10.1111/j.1365-2141.2011.08898.x. Epub 2011 Oct 8. Review.

PMID:
21980926
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Inhibiting aurora kinases reduces tumor growth and suppresses tumor recurrence after chemotherapy in patient-derived triple-negative breast cancer xenografts.

Romanelli A, Clark A, Assayag F, Chateau-Joubert S, Poupon MF, Servely JL, Fontaine JJ, Liu X, Spooner E, Goodstal S, de Cremoux P, Bièche I, Decaudin D, Marangoni E.

Mol Cancer Ther. 2012 Dec;11(12):2693-703. doi: 10.1158/1535-7163.MCT-12-0441-T. Epub 2012 Sep 25.

PMID:
23012245
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk